Cited by 9Coronary Interventions and Diagnosticsbiodegradable polymer synthesis and propertiesMagnesium Alloys: Properties and Applications

A novel paclitaxel eluting bioresorbable vascular stent with a super flexible stent structure and round cross section struts fabricated using 3D printing technology with a rotating platform

Open access
Liu, Wei, Li, Qingqing, Song, Ge, Lin, Zhiqi, Gong, Xiaofei, Feng, Hanqing, Zhao, Hugh Q, Zhou, Yujie +3 more·2025·Regenerative Biomaterials

Abstract

Bioresorbable stents (BRS) have emerged as a groundbreaking development in the field of percutaneous coronary intervention (PCI) as they address the long-standing concerns of metallic stents. Nevertheless, the observed higher thrombosis rates in the first generation BRS, i.e. ABSORB®, might be attributed to their thicker struts, slower degradation rate and structural dismantling of partially endothelialized stents. In this study, measures have been taken to overcome these limitations include reducing strut thickness, modifying the structural design to maintain radial strength with thinner round cross section struts and using a new material poly(L-lactide-co-ɛ-caprolactone) (PLCL 95/5) that is tougher and degrade faster than poly(L-lactic acid) (PLLA).Given the excellent biocompatibility of PLCL materials, the US FDA has approved their use in clinical applications. PLCL stents can be used to treat diseases such as tracheal stenosis and tracheoesophageal fistula, and can also be applied in the construction of other tissue engineering stents, such as nerve conduitsand fat filling stents. The newly designed coronary stents were fabricated using a 3D printing technology with a rotating platform, coated with a paclitaxel coating and comprehensive in vitro research was conducted. It was the first to undergo tests in animals. Results showed the novel paclitaxel eluting PLCL stents had super-flexible structure, thinner round cross-sectional struts, a faster degradation profile and satisfactory hemocompatibility. With a paclitaxel dose of 0.57 μg/mm2, the drug eluting stents showed very low degree of stenosis within 6 months of implantation in a porcine model. Overall, the results showed that the novel 3D printed PLCL drug eluting stent is a very promising candidate for next generation bioresorbable coronary stent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rb/rbaf073

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Through various fabrication techniques and by incorporating drugs, cells, or bioactive factors, PLCL has been successfully applied across diverse fields, including skin wound healing, neural repair, osteochondral regeneration, vascular and urethral graft fabrication, biological meshes, drug delivery, and stem cell culture.

    “Furthermore, through various fabrication techniques and by incorporating drugs, cells, or bioactive factors, PLCL has been successfully applied across diverse fields, including skin wound healing, neural repair, osteochondral regeneration, vascular and urethral graft fabrication, biological meshes, drug delivery, and stem cell culture [1, 18, 196, 225, 229–231].”

    From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [231]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [36]Valdes PJ, Akbar H, Kahloon RA, Diaz MA. Intracoronary Stents. 2025 Mar 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025. 29939565

Cited by

Sorted by citations

Authors
Liu, W., Li, Q., Song, G., Lin, Z., Gong, X., Feng, H., Zhao, H. Q., Zhou, Y., Wang, Y., Fan, Z., & Liu, Q.
Affiliations
  • Beijing Jishuitan Hospital (CN)
  • Beijing Advanced Medical Technologies, Ltd Inc , Beijing 102600, P. R.
  • Sichuan University (CN)
  • Capital Medical University (CN)
  • Fudan University (CN)
Corresponding author
  • Fan, Zhongyong
  • Liu, Qing
Venue
Regenerative Biomaterials
Published
2025
Volume
12
Pages
rbaf073-rbaf073
ISSN
  • 2056-3418 (ISSN-L)
  • 2056-3426
OpenAlex
W4412123419
Cited by
9
References
48
Citations by year
2026: 9
FWCI
8.47
Type
journal article
Language
en
Open access
Locations
  • Regenerative Biomaterials (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Physical Sciences › Materials Science › Biomaterials › biodegradable polymer synthesis and properties
  • Physical Sciences › Materials Science › Biomaterials › Magnesium Alloys: Properties and Applications
Keywords
paclitaxel-eluting stents, poly(L-lactide-co-ε-caprolactone), 3D printing, rotating platform, strut thickness, stent flexibility, stent degradation, hemocompatibility, percutaneous coronary intervention, porcine model, drug-eluting stents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review